Director Kraft Reports a $3.53 Million TKO Buy

We have an assortment of noteworthy buys from directors and investment firms as well as C-level executives and members of Congress to report today.

📌 TKO Group Holdings $TKO

Director Jonathan Kraft takes the spotlight with a $3.53 million buy. That’s a big-ticket commitment to an entertainment powerhouse – definitely one to watch if you’re keeping tabs on momentum turning in that stock.

📌 Janux Therapeutics $JANX

RA Capital isn’t done with biotech. The investment firm filed a fresh 13D reporting an increase in its $JANX stake from 17.55% to 19.90% in JANX. Large, concentrated bets like this in the Biotech space often hint at major conviction in a pipeline or upcoming catalyst.

📌 Blend Labs $BLND

Director Brian Sheth scooped up $1.96 million in shares, continuing a recent string of insider buys in the software/app space. Keep an eye on whether this wave of internal confidence translates into price action.

📌 Arcosa $ACA

President and CEO Antonio Carillo  put down $498,438 on the engineering and construction firm. Insider buying in infrastructure names can be noteworthy, especially if market conditions continue to shift more risk-off.

Here’s The Hot Corner, with data from March 10, 2025:

Click the table to enlarge it.

Political Power Plays

Rep. Jefferson Shreve reported buys in 35 different companies – everything from semiconductors (Broadcom $AVGO) to energy (Exxon $XOM) to big pharma (AbbVie $ABBV).

Purchase amounts generally fell between $15,000 and $50,000. The largest single buy was a purchase in an amount between $100,001 and $250,000 position in $AVGO.

That’s a noteworthy bet in a formerly leading sector currently underwater.